Experimental therapy of human endometrial cancers with a targeted cytotoxic bombesin analog AN-215: Low induction of multidrug resistance proteins
- 1 August 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (12) , 1824-1830
- https://doi.org/10.1016/j.ejca.2005.04.031
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- An overview of targeted treatments in cancerClinical Therapeutics, 2003
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Endometrial cancerCurrent Opinion in Oncology, 1999
- Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell LinesJNCI Journal of the National Cancer Institute, 1999
- High rate of MDR‐1 and heterogeneous pattern of MRP expression without gene amplification in endometrial cancerInternational Journal of Cancer, 1995
- Intrinsic Overexpression of Two Different Mechanisms of Resistance to Chemotherapy (P-Glycoprotein and GST-π) in Human Endometrial CarcinomaChemotherapy, 1994
- High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissueEuropean Journal Of Cancer, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patientsGynecologic Oncology, 1984